Sabra to Report Third-Quarter Results on Nov. 2 After Forecasting 7% Growth in Adjusted FFO
Key Facts
Markets are awaiting Sabra Health Care REIT’s third-quarter 2026 results after the market closes on Nov. 2. The company will discuss them on a conference call and webcast the following day at 10:00 a.m. Pacific time. Sabra confirmed the results date in its investor statement, while Hinge Health also listed its third-quarter results call for Nov. 2 on its investor relations page. Official materials available publicly do not include third-quarter results for either company, so the figures in the previous draft for Sabra’s net income or funds from operations cannot be confirmed, nor can Hinge’s results be described as record-breaking. It also cannot be confirmed that Sabra revised its full-year guidance alongside its results announcement. Before the figures are released, the focus is on comparison with previous guidance and second-quarter indicators published by the two companies.
In August, Sabra reaffirmed its forecast ranges for 2026, setting net income at $0.37 to $0.39 per diluted common share. It forecast funds from operations of $1.12 to $1.14 per share and adjusted funds from operations of $1.53 to $1.55. It also set a range for adjusted funds available of $1.58 to $1.60 per share, and adjusted funds available under the standardized measure of $1.59 to $1.61. The company said the midpoints of its adjusted funds from operations and adjusted funds available under the standardized measure ranges imply annual growth of approximately 7% and 8%, respectively. These ranges provide a basis for comparison when third-quarter results are released, but do not establish that the company has raised its guidance since August.
Sabra reported adjusted funds from operations of $0.38 per diluted common share and adjusted funds available of $0.40 per share in the second quarter, according to its published quarterly results. Operationally, net cash income at owned properties in the managed senior housing segment rose 13.7% year over year in the same quarter. By contrast, net debt to adjusted EBITDA stood at 4.61 times on June 30, 2026, a measure that puts debt burden among the indicators markets will track alongside property performance. Sabra operates as a healthcare real estate investment trust, and its subsidiaries own properties serving the sector in the United States and Canada. These activities provide context for reading its results, while second-quarter indicators remain separate from the awaited third-quarter figures.
Among the operational matters Sabra highlighted in August was the transfer of properties leased to Avamere. It said it had letters of intent to re-lease all 26 properties and expected the transition to be completed during the second half of 2026. The company estimated the properties’ combined annual cash rent at approximately $53 million. The expected timing puts the matter among the items that may be monitored when third-quarter results are released, while no information available here confirms whether the transition has been completed or its terms have changed. Sabra will release results after the market closes on Nov. 2, then present them on the investor call scheduled for Nov. 3.
Hinge Health reported revenue of $212.8 million in the second quarter of 2026, up 53% year over year from $139.1 million in the corresponding quarter of 2025. Free cash flow rose to $99.6 million, compared with $32.6 million a year earlier. Its customer count also increased 24% to 2,929 customers on June 30, compared with 2,359 customers on the same date a year earlier. In its published third-quarter outlook, the company set revenue at between $223 million and $225 million, equivalent to annual growth of 45% at the midpoint, and non-GAAP operating income at between $61 million and $63 million. Hinge describes its model as combining AI-powered care, wearable devices and access to clinical specialists to provide personalized, evidence-based care.